This test procedure overview does not replace the Quick Reference Instructions (QRI). Before you begin the test, it is important to read and follow the detailed instructions in the QRI.
Price per test: $10.95
Product Description
The Flowfex PLUS COVID-19 and Flu A/B Home Test is a rapid test for the detection and differentiation of SARS-CoV-2, Influenza A, and Influenza B protein antigens in anterior nasal swab specimens. Includes 1 test per box.
description
Flowflex PLUS COVID-19 and Flu A/B Home Test is a lateral flow immunoassay intended for the qualitative detection and differentiation of SARS-CoV-2, influenza A, and influenza B protein antigens.
This test is authorized for non-prescription home use with self-collected anterior nares nasal swab specimens from individuals aged 14 years or older, or with adult-collected anterior nasal swab specimens from individuals two (2) years or older. This test is only authorized for individuals with signs and symptoms of respiratory infection consistent with COVID-19 within the first six (6) days of symptom onset when tested at least twice over three days with at least 48 hours between tests. Clinical signs and symptoms of respiratory viral infection due to SARS-CoV-2 and influenza can be similar.
The Flowflex Plus COVID-19 and Flu A/B Home Test does not differentiate between SARS-CoV and SARS-CoV-2 viruses and is not intended to detect influenza C antigens. All negative SARS-CoV-2 results are presumptive.
This test procedure overview does not replace the Quick Reference Instructions (QRI). Before you begin the test, it is important to read and follow the detailed instructions in the QRI.
In the USA, this product has not been FDA cleared or approved, but has been authorized by FDA under an Emergency Use Authorization.
This product has been authorized only for the detection of proteins from SARS-CoV-2, influenza A and influenza B, not for any other viruses or pathogens.
The emergency use of this product is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug, and Cosmetic Act, 21 U.S.C. §360bbb- 3(b)(1), unless the declaration is terminated or authorization is revoked sooner.
For more information on COVID-19, please visit: www.cdc.gov/COVID19
ref: L03A-R0645
SKU: DTK-751506
CLIA WAIVED RAPID TESTS
CLIA LABORATORY
6320 Canoga Ave. Ste. 1500, FL 15
Woodland Hills, CA 91367
SIGN UP FOR OUR NEWSLETTER
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Read More
Name | Domain | Purpose | Expiry | Type |
---|---|---|---|---|
wpl_user_preference | completelabsystems.com | WP GDPR Cookie Consent Preferences | 1 year | HTTP |
Name | Domain | Purpose | Expiry | Type |
---|---|---|---|---|
_gid | completelabsystems.com | Google Universal Analytics short-time unique user tracking identifier. | 1 days | HTTP |
_ga | completelabsystems.com | Google Universal Analytics long-time unique user tracking identifier. | 2 years | HTTP |
Name | Domain | Purpose | Expiry | Type |
---|---|---|---|---|
_gat_gtag_UA_212460542_1 | completelabsystems.com | --- | Session | --- |
_ga_9YYXEQ0TN4 | completelabsystems.com | --- | 2 years | --- |